Search research articles
Contact Us
Filters
Showing results (51-60 of 76) with videos related to
Page
of 8
Sort By:
Metabolites
|
May 24, 2024
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry
Fabian Frankenfeld, Lea Wagmann, Anush Abelian, et al.
Drug Testing and Analysis
|
July 13, 2019
Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings
Lea Wagmann, Nora Hempel, Lilian H J Richter, et al.
Journal of Analytical Toxicology
|
May 2, 2025
Lateral flow immunoassay for amatoxins detection in human urine compared to liquid chromatography-high-resolution tandem mass spectrometry
Aline C Vollmer, Thomas P Bambauer, Candace B Bever, et al.
Scientific Reports
|
September 13, 2024
Rapid analysis of amatoxins in human urine by means of affinity column chromatography and liquid chromatography-high-resolution tandem mass spectrometry
Aline C Vollmer, Claudia Fecher-Trost, Candace S Bever, et al.
Toxicology and Applied Pharmacology
|
June 16, 2026
In-depth in vivo and in vitro investigation of metabolism and detectability of three novel methylprolintane psychostimulants by hyphenated mass spectrometry
Lea Wagmann, Anica Herter, Michael B Dybek, et al.
Journal of Analytical Toxicology
|
February 28, 2020
Toxicokinetics and Analytical Toxicology of Flualprazolam: Metabolic Fate, Isozyme Mapping, Human Plasma Concentration and Main Urinary Excretion Products
Lea Wagmann, Sascha K Manier, Thomas P Bambauer, et al.
Archives of Toxicology
|
September 29, 2025
In vitro toxicokinetics and metabolic profiling of methoxycathinones and methylthiocathinones using human liver systems and hyphenated mass spectrometry
Matthias D Kroesen, Tanja M Gampfer, Lea Wagmann, et al.
Archives of Toxicology
|
May 25, 2026
Metabolic fate and detectability of three novel fluoroprolintane psychostimulants: in vitro and in vivo characterization by hyphenated mass spectrometry
Lea Wagmann, Anica Herter, Michael B Dybek, et al.
Drug Testing and Analysis
|
March 15, 2026
Bioactivation and Metabolism of Amino Acid MDMA Prodrugs in Zebrafish Embryos, Human Liver S9, Whole Blood, and Microdosed Human Urine
Simon K Wellenberg, Lea Wagmann, Matthias D Kroesen, et al.
Journal of Analytical Toxicology
|
October 13, 2020
Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam
Lea Wagmann, Sascha K Manier, Christina Felske, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 76) with videos related to
Sort By:
Page
of 8
Metabolites
|
May 24, 2024
In Vivo and In Vitro Metabolic Fate and Urinary Detectability of Five Deschloroketamine Derivatives Studied by Means of Hyphenated Mass Spectrometry
Fabian Frankenfeld, Lea Wagmann, Anush Abelian, et al.
Drug Testing and Analysis
|
July 13, 2019
Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings
Lea Wagmann, Nora Hempel, Lilian H J Richter, et al.
Journal of Analytical Toxicology
|
May 2, 2025
Lateral flow immunoassay for amatoxins detection in human urine compared to liquid chromatography-high-resolution tandem mass spectrometry
Aline C Vollmer, Thomas P Bambauer, Candace B Bever, et al.
Scientific Reports
|
September 13, 2024
Rapid analysis of amatoxins in human urine by means of affinity column chromatography and liquid chromatography-high-resolution tandem mass spectrometry
Aline C Vollmer, Claudia Fecher-Trost, Candace S Bever, et al.
Toxicology and Applied Pharmacology
|
June 16, 2026
In-depth in vivo and in vitro investigation of metabolism and detectability of three novel methylprolintane psychostimulants by hyphenated mass spectrometry
Lea Wagmann, Anica Herter, Michael B Dybek, et al.
Journal of Analytical Toxicology
|
February 28, 2020
Toxicokinetics and Analytical Toxicology of Flualprazolam: Metabolic Fate, Isozyme Mapping, Human Plasma Concentration and Main Urinary Excretion Products
Lea Wagmann, Sascha K Manier, Thomas P Bambauer, et al.
Archives of Toxicology
|
September 29, 2025
In vitro toxicokinetics and metabolic profiling of methoxycathinones and methylthiocathinones using human liver systems and hyphenated mass spectrometry
Matthias D Kroesen, Tanja M Gampfer, Lea Wagmann, et al.
Archives of Toxicology
|
May 25, 2026
Metabolic fate and detectability of three novel fluoroprolintane psychostimulants: in vitro and in vivo characterization by hyphenated mass spectrometry
Lea Wagmann, Anica Herter, Michael B Dybek, et al.
Drug Testing and Analysis
|
March 15, 2026
Bioactivation and Metabolism of Amino Acid MDMA Prodrugs in Zebrafish Embryos, Human Liver S9, Whole Blood, and Microdosed Human Urine
Simon K Wellenberg, Lea Wagmann, Matthias D Kroesen, et al.
Journal of Analytical Toxicology
|
October 13, 2020
Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam
Lea Wagmann, Sascha K Manier, Christina Felske, et al.
Page
of 8